Outline & History2019-01-30T18:59:47+00:00

Home About Outline & History

A History of Innovation and Manufacturing Excellence

Denka Seiken Co., Ltd. is a publicly traded biomedical company founded in 1950 with its head office in Tokyo and manufacturing facilities in Niigata, Japan. We develop, manufacture and distribute high quality in vitro diagnostic reagents and vaccines. Top export products include direct HDL, LDL and sdLDL reagents, latex-enhanced serum protein tests for hsCRP, rheumatoid factor, myglobin, ferritin and others. Rapid diagnostic test kits for MRSA, E. coli O157, parvo B19, norovirus and influenza viruses are also market leaders in many countries around the world. Denka Seiken possesses numerous collaborative business relations with world-wide top ten diagnostic companies, and has ISO13485 and ISO14001 certification as well as a number of products FDA-cleared for sale in the US. More recently, the company has focused on contract R&D and manufacturing for immunochemistry products.

In 2003 Denka Seiken established its first international branch office in the UK to assist in the promotion of its extensive line of diagnostics reagents for clinical chemistry and infectious disease testing. The US branch office was established in the following year, complementing the UK office for promotional marketing activities, setting up of clinical trials and new product evaluations, and providing FDA-related regulatory support to the head office.

Denka Seiken

Timeline

ABOUT

A History of Innovation and Manufacturing Excellence
Denka Seiken Co., Ltd. is a publicly traded biomedical company founded in 1950 with its head office in Tokyo and manufacturing facilities in Niigata, Japan.

Read More

Sustained and Growing Global Demand for Denka Seiken Products.
Denka Seiken Co., Ltd. is a publicly traded biomedical company founded in 1950 with its head office in Tokyo and manufacturing facilities in Niigata, Japan.

Read More

Total R&D Commitment to Enhance Technology Focused on Promotion of Health
Having introduced genetic modification technology, Denka Seiken became the first commercial producer in Japan of Norovirus(NV) antibodies, and developed in vitro diagnostic tests.

Read More

Ensuring Quality, Safety, Reliability and Effectiveness For All Our Products.
Denka Seiken is determined to make a positive contribution to society as a manufacturer and supplier of a broad range of vaccines and invitro diagnostic test reagents.

Read More

Denka Seiken Co., Ltd.

Head Office:
Nihonbashi Mitsui Tower
1-1 Nihonbashi-Muromachi 2-chome,
Chuo-ku, Tokyo 103-8338, JAPAN

Established:
February 11, 1950

Paid-in Capital:
1,000 million YEN(JP)

Number of Employees:
725 (As of April 1, 2017)

Business:
Production, sales and import and export of clinical chemistry, immunochemistry, bacteriological and virological diagnostic reagents and food/environment testing reagent

Fiscal year ends:
March

Offices:
Factories:
Niigata Plant, Kagamida Plant (Gosen-shi, Niigata)

Branch Offices:
Tokyo, Osaka, Kanetsu

Sales Offices:
Sapporo, Sendai, Nagoya, Hiroshima, Fukuoka

Subsidiaries:
Denka Seiken UK Limited
Denka Seiken USA Incorporated
Denka Seiken (SHANGHAI) Co.,Ltd.